Test Your Knowledge on Early NSCLC!
A quiz based on the latest early NSCLC news and studies.
Read More
Tecentriq – eBook Display Banners Condition Spotlight – 54103
A Focus on eNSCLC eBook
A curated ebook on eNSCLC featuring recent studies, findings, and opinions from thought leaders.
Read More
Use of Surgical Quality Metrics Improves Early NSCLC Outcomes
Adhering to surgical quality metrics may improve overall survival and recurrence-free survival for...
Read More
Sublobar Resection Not Inferior to Lobectomy in Early-Stage NSCLC
In terms of disease-free survival, sublobar resection was not inferior to lobectomy for patients...
Read More
Even With Delay, Surgery Improves Survival in Early NSCLC Versus Stereotactic Radiation
Surgery was superior to stereotactic radiation for early non-small cell lung cancer, even in the...
Read MoreAnalyzing SEER Medicare Data for eNSCLC Patients
The following is the summary of “Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare Data” published in the December 2022 issue of Lung Cancer by West, et al. As...
Read More
Survival and Treatment Patterns of Early-stage NSCLC Patients with Locoregional Recurrence
The following is the summary of “Treatment patterns and survival of patients with locoregional...
Read More
Wedge Resections & Underutilization of Adv Chemotherapy Linked with Non-examination of LN in eNSCLC
The following is the summary of “946P – Non-examination of lymph nodes (LN) in early-stage...
Read More
Increased SBRT in eNSCLC Reduces Racial Disparities & Mortality
For patients with early-stage non-small cell lung cancer (eNSCLC), increased use of stereotactic...
Read More
SBRT Utilization Associated With Improved Early-Stage NSCLC Survival and Reduced Disparities
The following is the summary of “Increased Utilization of Stereotactic Body Radiotherapy is...
Read More
Efficacy of EGFR-Tyrosine Kinase Inhibitors and Potential Treatment Strategy Affected by TP53 Mutations
The following is the summary of “Impact of TP53 Mutations on EGFR-Tyrosine Kinase Inhibitor...
Read More
Circulating Tumor DNA IDs Relapse Risk in Early NSCLC
The identification of circulating tumor DNA (ctDNA) following initial treatment among patients...
Read More
#VisualAbstract: Segmentectomy is superior to lobectomy for patients with early-stage non-small cell lung cancer
1. Patients who underwent segmentectomy reported a significantly greater 5-year overall survival...
Read More
Sub-Lobar Resection Good For Geriatric Patients With eNSCLC
While thoracoscopic sub-lobar resection (SR) appears to result in similar oncologic outcomes...
Read More
Aberrant Lipid Metabolism ID’d in Early-Stage Lung Cancer
THURSDAY, Feb. 3, 2022 (HealthDay News) — A plasma assay that detects dysregulated lipids...
Read More
Diagnosing Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC) and the Recommended Course of Action
A research exhibited the contemporary approved approaches for the workup required to diagnose...
Read More